Timothy Corn
Chief Tech/Sci/R&D Officer chez OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC
Profil
Timothy Henry Corn currently works at Neuro Foundation, as Chairman from 2013, Physiomics Plc, as Independent Non-Executive Director from 2022, Oxford Cannabinoid Technologies Holdings Plc, as Executive Director & Chief Medical Officer from 2023, Nerve Tumours Uk, as Trustee from 2019, and Nodenza, Inc., as Chief Medical Officer.
Dr. Corn also formerly worked at ReNeuron Group Plc, as Independent Non-Executive Director from 2021 to 2022, Circassia Ltd., as Non-Executive Director, Head-Clinical & Regulatory from 2011 to 2014, HRA Pharma Development SARL, as Independent Non-Executive Director from 2016 to 2019, Neurocentrx Pharma Ltd., as Non-Executive Director, Niox Group Plc, as Independent Non-Executive Director from 2006 to 2017, Elan Corp.
Plc, as Principal, Athena Neurosciences LLC, as Principal, Zeneus Pharma Ltd., as Chief Medical Officer, EUSA Pharma, Inc., as Chief Medical Officer, Organon Pharma (UK) Ltd., as Principal, Jazz Pharmaceuticals UK Ltd., as Chief Medical Officer, Eusa Pharma International Ltd., as Chief Medical Officer, and Izana Bioscience Ltd., as Chief Medical Officer from 2018 to 2021.
Dr. Corn received his graduate degree from Imperial College London and doctorate degree from King's College London.
Postes actifs de Timothy Corn
| Sociétés | Poste | Début |
|---|---|---|
| PHYSIOMICS PLC | Director/Board Member | 01/04/2022 |
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 08/06/2023 |
| Neuro Foundation | Chairman | 01/07/2013 |
| Nodenza, Inc. | Chief Tech/Sci/R&D Officer | - |
| Nerve Tumours Uk | Director/Board Member | 01/07/2019 |
Anciens postes connus de Timothy Corn
| Sociétés | Poste | Fin |
|---|---|---|
| RENEURON GROUP PLC | Chairman | 30/06/2021 |
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The private company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Director/Board Member | 01/07/2019 |
| NIOX GROUP PLC | Director/Board Member | 26/05/2017 |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Timothy Corn
| Imperial College London | Graduate Degree |
| King's College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| RENEURON GROUP PLC | Health Technology |
| PHYSIOMICS PLC | Commercial Services |
| NIOX GROUP PLC | Health Services |
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Health Technology |
| Entreprise privées | 14 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Commercial Services |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Distribution Services |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Health Technology |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Health Technology |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Health Technology |
Neurocentrx Pharma Ltd.
 Neurocentrx Pharma Ltd. Pharmaceuticals: MajorHealth Technology Neurocentrx Pharma Ltd. is a British pharmaceutical company that manufactures and distributes medicines. The company is based in Edinburgh, UK. Neurocentrx Pharma was founded by Howard Marriage, Ronald M. Lindsay, and Carmel Reilly. Carmel Reilly has been the CEO since incorporation. | Health Technology |
Eusa Pharma International Ltd.
 Eusa Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Eusa Pharma International Ltd. is a Gibraltar specialty biopharmaceutical company that identifies, develops, and commercializes pharmaceutical products. | Health Technology |
| Neuro Foundation | Miscellaneous |
Izana Bioscience Ltd.
Izana Bioscience Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The private company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017. | Health Technology |
| Nerve Tumours Uk | |
| Nodenza, Inc. |
